Evaluation of a Specific Transdermal Cannabidiol Product for Chronic Musculoskeletal Joint Pain.
WithdrawnPhase 1NCT05002114
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Double-blind, randomized into two arms (TC and TP): patients get either topical cannabidiol or topical placebo up to three times daily. Inclusion criteria will be chronic joint pain with intent to treat or currently treated with opioids. Exclusion criteria will include current cannabis use, severe medical illness or lacking in capacity to be involved in study. TC and TP will be prescribed for use TID in predefined dosages and quantities.
Study details
- Official title
- Evaluation of a Specific Transdermal Cannabidiol Product for Chronic Musculoskeletal Joint Pain.
- Conditions
- Musculoskeletal Joint Pain
- Interventions
- Sponsor
- Louisiana State University Health Sciences Center Shreveport
- Start date
- 2023-01
- Primary completion
- 2023-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria 1. Diagnosis of chronic musculoskeletal joint pain (arthritis, traumatic arthritis, osteoarthritis) 2. Adults ages 18 and over. 3. Medically stable without significant medical illness that would preclude treatment with either pharmacologic agent. 4. Have a safe, stable, living environment. Exclusion Criteria 1. Unable to consent for research project. 2. Individuals less than 18 years of age. 3. Individuals with rheumatoid or other autoimmune types of arthritis. 4. Individuals diagnosed with SUD especially cannabis, as this may confound results.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05002114